Moderna’s coronavirus vaccine has an ’80 to 90% chance’ of FDA approval, the biotech’s CEO claims
Biotech firm Moderna’s coronavirus vaccine has an ’80 to 90% chance’ of FDA approval, claims CEO as they head into the first large US human trial of 30,000 people in July Stephen Bancel, the CEO of Moderna Therapeutics, believes the company’s coronavirus vaccine has an 80% to 90% chance of being approved by the FDA … Read more